These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6999370)

  • 21. Calcium and phosphorus metabolism in uremia and renal transplantation: an experimental model.
    Mitchell TS; Lee S; Gittes RF
    Invest Urol; 1974 Nov; 12(3):186-92. PubMed ID: 4613687
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chlorothiazide on 1,25-dihydroxyvitamin D3, parathyroid hormone, and intestinal calcium absorption in the rat.
    Favus MJ; Coe FL; Kathpalia SC; Porat A; Sen PK; Sherwood LM
    Am J Physiol; 1982 Jun; 242(6):G575-81. PubMed ID: 6896403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
    Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure.
    Brickman AS; Coburn JW; Massry SG; Norman AW
    Ann Intern Med; 1974 Feb; 80(2):161-8. PubMed ID: 4359739
    [No Abstract]   [Full Text] [Related]  

  • 26. The intestinal absorption of phosphorus. Its relation to calcium absorption and to treatment with vitamin D in osteomalacia, parathyroid dysfunction and chronic renal failure.
    Stamp TC
    Clin Sci; 1972 Apr; 42(4):16P. PubMed ID: 5020269
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium and phosphorus metabolism in nephrotic syndrome.
    Lim P; Jacob E; Tock EP; Pwee HS
    Q J Med; 1977 Jul; 46(183):327-38. PubMed ID: 303365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical importance of disorders of vitamin D metabolism].
    Flury W
    Schweiz Med Wochenschr; 1978 Jan; 108(4):129-33. PubMed ID: 341302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of intestinal absorption of calcium in patients with renal failure.
    Coburn JW; Koppel MH; Brickman AS; Massry SG
    Kidney Int; 1973 Apr; 3(4):264-72. PubMed ID: 4600294
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of 1-alpha-hydroxycholecalciferol (1 alpha-OH/D3) and 24,25-dihydroxycholecalciferol (24, 25-OH)2D3) on calcium and phosphorus metabolism in chronic renal failure].
    Galus K; Szymendera J; Jelińska S; Schabowska M; Jelonek A
    Pol Arch Med Wewn; 1979 Feb; 61(2):105-12. PubMed ID: 440977
    [No Abstract]   [Full Text] [Related]  

  • 31. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.
    Evenepoel P; Meijers BK; de Jonge H; Naesens M; Bammens B; Claes K; Kuypers D; Vanrenterghem Y
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1829-36. PubMed ID: 18922992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women.
    Gennari C; Agnusdei D; Nardi P; Civitelli R
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1288-93. PubMed ID: 2229286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium and phosphorus in diet therapy of uremia.
    Schoolwerth AC; Engle JE
    J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium and phosphorus metabolism disturbances after renal transplantation.
    Ramezani M; Einollahi B; Asl MA; Nafar M; Pourfarziani V; Moradi M; Samadpour A; Alghasi M; Davoudi F
    Transplant Proc; 2007 May; 39(4):1033-5. PubMed ID: 17524884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in phosphorus-calcium metabolism in experimental renal insufficiency and after administration of dihydrotachysterol and thyrocalcitonin].
    Migunova NA; Ermolenko VM; Nikiforova NV; Malinina NV; Blazheevich NV
    Vopr Med Khim; 1976; 22(3):400-6. PubMed ID: 1030898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disturbances in mineral metabolism after successful renal transplantation.
    Sakhaee K; Brinker K; Helderman JH; Bengfort JL; Nicar MJ; Hull AR; Pak CY
    Miner Electrolyte Metab; 1985; 11(3):167-72. PubMed ID: 3892264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
    Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications.
    Miozzari M; Ambühl PM
    Nephrol Dial Transplant; 2004 Oct; 19(10):2615-21. PubMed ID: 15280521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verapamil improves defective duodenal calcium absorption in experimental chronic renal failure.
    Goligorsky MS; Chaimovitz C; Shany S; Rapoport J; Sharony Y; Haichenco J
    Miner Electrolyte Metab; 1986; 12(5-6):363-70. PubMed ID: 3807833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.